| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 2.48 Billion | USD 8.55 Billion | 13.2% | 2024 |
FrequentlyAsked Questions
The global radiation dose-reduction system market is expected to grow due to increasing awareness of radiation safety, rising use of medical imaging, stringent regulatory guidelines, and advancements in dose-reduction technologies.
According to a study, the global radiation dose-reduction system market size was worth around USD 2.48 Billion in 2024 and is expected to reach USD 8.55 Billion by 2034.
The global radiation dose-reduction system market is expected to grow at a CAGR of 13.2% during the forecast period.
North America is expected to dominate the radiation dose-reduction system market over the forecast period.
Leading players in the global radiation dose-reduction system market include Bayer AG, Bracco Imaging SpA,Fujifilm Holdings Corporation,GE Healthcare, Medsquare, Novarad Corporation, PACShealth LLC, Koninklijke Philips N.V., Qaelum NV and Sectra AB, among others.
The report explores crucial aspects of the radiation dose-reduction system market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients